Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

2,650.00p
   
  • Change Today:
      11.00p
  • 52 Week High: 2,673.00
  • 52 Week Low: 1,701.50
  • Currency: UK Pounds
  • Shares Issued: 230.50m
  • Volume: 664,061
  • Market Cap: £6,108m
  • RiskGrade: 173

HIK Overview

Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The company sells 113 branded and non-branded generic pharmaceutical products in 34 countries worldwide. The majority of Hikma’s operations are in the United States, the Middle East and North Africa Region and Europe.

Key Personnel

CEO: Sigurdur Olafsson
Company Secretary: Peter Speirs
Executive Chairman: Said Darwazah
Executive Vice Chairman: Mazen Darwazah
Independent Non-Executive Director: Pamela Kirby
Independent Non-Executive Director: Cynthia Schwalm
Independent Non-Executive Director: John J. Castellani
Independent Non-Executive Director: Douglas Hurt
Independent Non-Executive Director: Mary (Nina) Henderson
Independent Non-Executive Director: Pat Butler
Senior Independent Director: Robert Pickering
Non-Executive Dir: Ali Al-Husry

Contact Details

Address: 1 New Burlington Place, London,United Kingdom, W1S 2HR
Phone: +44 (0)20 7399 2760
Fax: +44 (0)20 7399 2761
Website: http://www.hikma.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE 100FTSE 350FTSE All-Share
Overseas Listings: BATSLON:HIKL
ISIN: GB00B0LCW083

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 2,650.00p
Change Today 11.00p
% Change 0.42 %
52 Week High 2,673.00
52 Week Low 1,701.50
Volume 664,061
Shares Issued 230.50m
Market Cap £6,108m
RiskGrade 173

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
90.11% below the market average90.11% below the market average90.11% below the market average90.11% below the market average90.11% below the market average
17.86% above the sector average17.86% above the sector average17.86% above the sector average17.86% above the sector average17.86% above the sector average
Price Trend
75.68% above the market average75.68% above the market average75.68% above the market average75.68% above the market average75.68% above the market average
8.77% above the sector average8.77% above the sector average8.77% above the sector average8.77% above the sector average8.77% above the sector average
Income
83.92% below the market average83.92% below the market average83.92% below the market average83.92% below the market average83.92% below the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average
Growth
55.30% above the market average55.30% above the market average55.30% above the market average55.30% above the market average55.30% above the market average
88.89% above the sector average88.89% above the sector average88.89% above the sector average88.89% above the sector average88.89% above the sector average

What The Brokers Say

Strong Buy 9
Buy 2
Neutral 1
Sell 1
Strong Sell 0
Total 13
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Interim Final
Ex-Div 20-Aug-20 19-Mar-20
Paid 21-Sep-20 07-May-20
Amount 16.00¢ 30.00¢

Trades for 18-Sep-2020

Time Volume / Share Price
17:11 8,090 @ 2,649.86p
17:11 4,460 @ 2,649.86p
17:11 4,167 @ 2,652.07p
17:11 7,551 @ 2,652.08p
17:11 2,037 @ 2,652.58p

HIK Key Personnel

CEO Sigurdur Olafsson

Top of Page